Nanoform Finland Oyj Company Description

Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharmaceutical and biotech industry in Europe and the United States.

The company provides nanoparticle production services using its proprietary controlled expansion of supercritical solutions technology that enables clients, as well as designs and develops nanoformed drug substance.

It also offers STARMAP, as a secure online portal to perform large numbers of in-silico CESS experiments The company was founded in 2008 and is headquartered in Helsinki, Finland.

Nanoform Finland Oyj

Country	Finland
Founded	2008
Industry	Biotechnology
Sector	Healthcare
Employees	165
CEO	Edward Haeggstrom

Contact Details

Address: Cultivator II Helsinki, 00790 Finland
Phone	358 2937 00150
Website	nanoform.com

Stock Details

Ticker Symbol	NANOFH
Exchange	Nasdaq Helsinki
Fiscal Year	January - December
Reporting Currency	EUR
ISIN Number	FI4000330972
SIC Code	8731

Key Executives

Name	Position
Prof. Edward Olof Haeggstrom	Co-Founder and Chief Executive Officer
Albert Alexander Haeggstrom	Chief Financial Officer and Director
Henri von Haartman	Director of Investor Relations
Peter Hanninen	General Counsel and Chief Development Officer
Dr. David Rowe	Head of Manufacturing
Christian Jones	Chief Commercial Officer
Antonio Da Silva	Chief of Business Operations
Johanna Kause	Chief Quality Officer
Dr. Jamie Unwin	Vice President of Strategic Insight